Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-07-24FDA Approved: DOXEPIN — Original Application (Strides Pharma Science Limited)
FDA approved an original application for doxepin hydrochloride (generic doxepin) by Strides Pharma Science Limited, expanding the availabili…
-
FDA approval · 2020-07-21FDA Approved: PAROXETINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Paroxetine hydrochloride from Apotex Corp., enabling continued marketing of a generic product.
-
FDA approval · 2020-07-10FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for a generic Bupropion Hydrochloride Extended-Release (XL) product.
-
FDA approval · 2020-06-30FDA Approved: BUPROPION HYDROCHLORIDE (XL) — Supplemental Application (ScieGen Pharmaceuticals,Inc.)
FDA approved a supplemental application to authorize the marketing of Bupropion Hydrochloride (XL) from ScieGen Pharmaceuticals, the extende…
-
FDA approval · 2020-06-30FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Bupropion Hydrochloride from Rising Pharma Holdings, Inc., for a generic product under an AN…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-06-30FDA Approved: BUPROPION HYDROCHLORIDE (XL) — Supplemental Application (Exelan Pharmaceuticals Inc.)
FDA approved a supplemental application for bupropion hydrochloride extended-release (XL) from Exelan Pharmaceuticals Inc., enabling continu…
-
FDA approval · 2020-06-10FDA Approved: FLUOXETINE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's generic fluoxetine through an Original Application (ANDA).
-
FDA approval · 2020-05-19FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved a supplemental application for trazodone hydrochloride from Oxford Pharmaceuticals, LLC under an ANDA.
-
FDA approval · 2020-04-29FDA Approved: REMERONSOLTAB — Supplemental Application (Organon LLC)
FDA approved a supplemental application for REMERONSOLTAB (mirtazapine) submitted by Organon LLC.
-
FDA approval · 2020-04-29FDA Approved: REMERON — Supplemental Application (Organon LLC)
FDA approved a supplemental application for REMERON (mirtazapine) from Organon LLC. The approval updates the labeling to reflect the approve…
-
FDA approval · 2020-04-28FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
The FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2020-04-20FDA Approved: CYMBALTA — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Cymbalta (duloxetine hydrochloride) from Eli Lilly, granting updated labeling under the NDA.
-
FDA approval · 2020-04-20FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for trazodone hydrochloride by Zydus Lifesciences Limited.
-
FDA approval · 2020-04-20FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approves a supplemental application for trazodone hydrochloride from Apotex Corp, authorizing a generic version of the antidepressant. T…
-
FDA approval · 2020-04-15FDA Approved: NORTRIPTYLINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Nortriptyline Hydrochloride from Teva Pharmaceuticals USA, Inc., updating or expanding the d…
-
FDA approval · 2020-04-14FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for venlafaxine by BluePoint Laboratories, expanding its generic availability.
-
FDA approval · 2020-04-14FDA Approved: VENLAFAXINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Venlafaxine hydrochloride (generic Venlafaxine) by Aurobindo Pharma Limited.
-
FDA approval · 2020-04-10FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for venlafaxine from Alembic Pharmaceuticals.
-
FDA approval · 2020-04-08FDA Approved: FLUOXETINE — Original Application (Aurobindo Pharma Limited)
FDA approved a generic fluoxetine product from Aurobindo Pharma Limited under an Original Application (ANDA 213286). Fluoxetine is an SSRI i…
-
FDA approval · 2020-04-07FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Original Application (AiPing Pharmaceutical, Inc.)
FDA approved a generic amitriptyline hydrochloride product from AiPing Pharmaceutical, Inc. under an original application.
-
FDA approval · 2020-03-12FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Advagen Pharma Ltd.)
FDA approved the original application for venlafaxine hydrochloride by Advagen Pharma Ltd., authorizing a generic version of this antidepres…
-
FDA approval · 2020-03-05FDA Approved: BUPROPION — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Bupropion by Zydus Pharmaceuticals USA Inc.
-
FDA approval · 2020-03-04FDA Approved: REMERON — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for REMERON (mirtazapine) filed by Organon LLC.
-
FDA approval · 2020-03-04FDA Approved: REMERONSOLTAB — Supplemental Application (Organon LLC)
The FDA lists a supplemental application for REMERONSOLTAB (mirtazapine) submitted by Organon LLC, indicating an ongoing regulatory action f…
-
FDA approval · 2020-02-21FDA Approved: SERTRALINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for sertraline from Heritage Pharmaceuticals (d/b/a Avet), signaling approval of a change or additio…